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Lineage Tracing of Resident Tendon Progenitor Cells
during Growth and Natural Healing
Nathaniel A. Dyment1*, Yusuke Hagiwara1, Brya G. Matthews1, Yingcui Li1,2, Ivo Kalajzic1, David W. Rowe1
1 Department of Reconstructive Sciences, College of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States of America,
2 Department of Biology, College of Arts and Sciences, University of Hartford, Hartford, Connecticut, United States of America

Abstract
Unlike during embryogenesis, the identity of tissue resident progenitor cells that contribute to postnatal tendon growth
and natural healing is poorly characterized. Therefore, we utilized 1) an inducible Cre driven by alpha smooth muscle actin
(SMACreERT2), that identifies mesenchymal progenitors, 2) a constitutively active Cre driven by growth and differentiation
factor 5 (GDF5Cre), a critical regulator of joint condensation, in combination with 3) an Ai9 Cre reporter to permanently label
SMA9 and GDF5-9 populations and their progeny. In growing mice, SMA9+ cells were found in peritendinous structures and
scleraxis-positive (ScxGFP+) cells within the tendon midsubstance and myotendinous junction. The progenitors within the
tendon midsubstance were transiently labeled as they displayed a 4-fold expansion from day 2 to day 21 but reduced to
baseline levels by day 70. SMA9+ cells were not found within tendon entheses or ligaments in the knee, suggesting a
different origin. In contrast to the SMA9 population, GDF5-9+ cells extended from the bone through the enthesis and into a
portion of the tendon midsubstance. GDF5-9+ cells were also found throughout the length of the ligaments, indicating a
significant variation in the progenitors that contribute to tendons and ligaments. Following tendon injury, SMA9+
paratenon cells were the main contributors to the healing response. SMA9+ cells extended over the defect space at 1 week
and differentiated into ScxGFP+ cells at 2 weeks, which coincided with increased collagen signal in the paratenon bridge.
Thus, SMA9-labeled cells represent a unique progenitor source that contributes to the tendon midsubstance, paratenon,
and myotendinous junction during growth and natural healing, while GDF5 progenitors contribute to tendon enthesis and
ligament development. Understanding the mechanisms that regulate the expansion and differentiation of these
progenitors may prove crucial to improving future repair strategies.
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to this niche [4]. Others have suggested that perivascular
progenitors exist within the tendon midsubstance and paratenon
[5,6]. In addition, researchers are beginning to isolate cells from
tendon that express stem/progenitor markers, show multi-potency
in vitro, and improve tendon repair in vivo [7,8]. However,
detailed in vivo lineage tracing of tendon progenitors demonstrating their expansion potential during growth and their reparative
potential following injury has not been pursued in great detail.
Alpha smooth muscle actin (aSMA), while highly expressed in
smooth muscle cells within blood vessel walls, is also a marker for a
mesenchymal progenitor that contributes to bone, fat, and
perivascular lineages [9–12]. aSMA is highly expressed in early
stages of primary bone marrow stromal cultures and aSMA+
progenitors within the stromal compartment contribute to
trabecular and endocortical bone formation while progenitors
within the periosteum contribute to callus formation during
fracture healing [9]. aSMA progenitors within the periodontium
contribute to the periodontal ligament and cellular cementum
during growth and may have a perivascular origin [13]. While
aSMA is expressed by myofibroblasts during early tendon healing
[14], it is unclear whether aSMA can identify progenitors within
tendon.

Introduction
Understanding the origin of resident tendon progenitors and the
factors that influence their differentiation are critical to designing
novel repair strategies. During development, tendon progenitors
originate in the sclerotome and express the basic-helix-loop-helix
transcription factor scleraxis (Scx) [1]. Scx+ cells contribute to the
tendon midsubstance as it condenses between the adjacent muscle
and cartilage. Sox9, a SRY-related transcription factor which is
important in cartilage differentiation, is co-expressed with Scx in
cells that eventually give rise to the tendon fibrocartilage within the
enthesis [2,3]. Sox9+ cells beneath this layer contribute to the
underlying bone while the adjacent muscle is derived from the
myotome. While our understanding of the origin of progenitors
that give rise to tendon in the embryo is improving, little is known
about the anatomical origin of resident progenitors within the
tendon that contribute to these regions during postnatal growth,
how these cells proliferate and expand in 3D space during growth,
and whether these cells also contribute to adult natural healing
following injury.
Recent studies have begun to identify and characterize the
progenitor niche within tendon. Bi et al showed that the small
leucine rich proteoglycans fibromodulin and biglycan contribute
PLOS ONE | www.plosone.org
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Growth differentiation factor 5 (Gdf5) is a crucial regulator of
joint development and Gdf5+ progenitors contribute to the
formation of intra-articular structures including articular cartilage,
ligaments, fibrocartilage, and synovial lining [15]. Gdf5 deficiency
also delays tendon healing [16] but little is known whether Gdf5
regulates tendon development and maturation. The tendon
enthesis forms in a modular fashion from Scx and Sox9
progenitors within bone eminences near joints that do not arise
from the primary cartilage [3]. In fact, these Scx/Sox9 coexpressing cells likely originate from the GDF5+ interzone and
extend to the lateral edges of the joint to form the eminences and
tendon attachments.
The objective of this study is to identify and characterize the
expansion of tissue resident tendon progenitors that contribute to
normal cell turnover during growth and natural healing during
adulthood. Through detailed lineage tracing of SMA9+ progenitor
cells, we found that SMA9+ cells in the tendon midsubstance are
an amplifying progenitor population during growth. These cells do
not contribute to the fibrocartilage within the tendon enthesis and
ligamentous cells within the knee, which originate from a Gdf5
lineage. Finally, SMA9+ progenitors in the paratenon are the
main contributors to the healing response following injury in the
adult patellar tendon.

Lineage Tracing during Tendon Growth
Two intraperitoneal injections of tamoxifen (Sigma Aldrich)
were delivered on consecutive days to 3–4 week old SMA9 or
SMA9-ScxGFP mice at a dose of 75 mg/g body weight. The
SMA9 labeled cells were then analyzed on 2, 21, 42, and 70 days
following tamoxifen treatment to assess their amplification during
growth, characteristic of a resident progenitor population (n = 3–5
per time point). The GDF5-9 mice were analyzed at the ages of P0
(day of birth) and P56 (8 week old) (n = 3 per time point).

Patellar Tendon Injury
Full-length, full-thickness, central third patellar tendon defects
were created in adult SMA9 and SMA9-ScxGFP mice (average
age = 2363 weeks). Following aseptic preparation, two #11
scalpel blades were clamped together with needle holders and
used to make longitudinal incisions to create the defect (0.4 mm
wide). The central region of the tendon was then excised and the
skin was closed with 5–0 nylon sutures. The contralateral limbs
were treated as uninjured controls. The animals were allowed free
movement within their cages until two photon and histological
analysis at 1, 2, and 5 weeks post-injury (n = 5 per time point).

Histology and Immunohistochemistry

This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Connecticut Health Center
(Protocol Number: 100547-1015). All surgery was performed
under isoflurane anesthesia, and all efforts were made to minimize
suffering.

Animals were euthanized via CO2 asphyxiation. Limbs were
fixed in 10% formalin for 1–2 days at 4uC and then imaged on the
two photon microscope. The samples were then transferred to
30% sucrose overnight and embedded in cryomatrix (Thermofisher Scientific). Thin sections (8 mm) were made in several
tendons in both the fore and hind limbs using a cryofilm technique
(Section-lab, Hiroshima, Japan) [20,21] on a Leica CM3050S
cryostat. Natural healing sections were blocked (Power Block;
Biogenex) and stained with anti-tenascin-C (1:500; Abcam)
overnight at 4uC. The slides were incubated with a secondary
antibody (Alex Fluor IgG 647; Life Technologies), counterstained
with DAPI, and imaged on a Zeiss Imager-Z1 microscope.

Transgenic Mice

Two Photon Imaging

Materials and Methods
Ethics Statement

Two Cre driver transgenic mice were utilized in this
study. aSMACreERT2. The tamoxifen-inducible aSMA-

Formalin fixed limbs were submersed in 1X PBS during
imaging on the Prairie Ultima IV multiphoton microscope using a
20X/0.95W Olympus water immersion objective. All fluorophores
(GFP and tdTomato) and second harmonic generation (SHG) for
collagen were visualized at an excitation wavelength of 890 nm
and bandpass filters of 435–485 nm (SHG), 500–550 nm (GFP),
and 570–620 nm (tdTomato). Multiple tiled stacks (4596459 mm/
tile) were acquired at either 2566256 or 5126512 resolution with
z-depth increments of 1.8 mm. Tiled stacks were stitched using the
grid/collection stitching plugin [22] and 3D reconstructions were
created using the 3D viewer plugin [23] within Fiji image analysis
software [24].

CreERT2 mice, which label a mesenchymal progenitor cell
population, were described previously [9]. GDF5Cre: The
constitutively active GDF5Cre mice were shown previously to
contribute to several intra-articular structures [17].
Lineage tracing combinations. The Cre driver mice were
crossed with the Ai9 Cre reporter mouse line [18] (Jackson Labs),
which contains a loxP-flanked STOP cassette that prevents
transcription of CAG promoter-driven expression of tdTomato
fluorescent protein, resulting in aSMACreERT2-Ai9 (SMA9) and
GDF5Cre-Ai9 (GDF5-9) mice. In this strategy cell populations
that are the progeny of the cells that expressed the Cre driver at
the time of tamoxifen administration (SMA9) or at anytime in the
animal’s life (GDF5-9) will express the red fluorescent signal of Ai9
due to Cre-mediated excision of the STOP cassette.
Tendon and ligament marker. Along with anatomical
location, ScxGFP mice were used to clearly define cells within
tendon and ligaments [19,20]. These animals were crossed with
the SMA9 mice to generate a triple transgenic animal (SMA9ScxGFP) that can trace a progenitor cell into a cell type within the
tendon and ligament lineages.
A total of 52 transgenic mice were used for this study, including
22 and 30 transgenic mice for the growth and injury studies,
respectively.

PLOS ONE | www.plosone.org

Image Analysis
All image quantification was done using Fiji image analysis
software [24].
Growth study. The number of SMA9+ cells within the
tendon midsubstance were quantified from sagittal sections of the
patellar tendon at 2, 21, and 70 days following the last tamoxifen
injection. A region of interest was manually drawn to capture the
tendon midsubstance without the proximal or distal attachments.
Eight-bit grayscale images from the dapi channel were converted
to binary images by setting an equivalent threshold across the
treatment groups. A watershed was applied to segment nuclei
which were touching. The number of nuclei was then counted
using the analyze particles function within Fiji. Since the
2
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aligned along the tendon axis and are situated between densely
packed collagen fibers.
In addition to cells within and around the tendon midsubstance,
SMA9+ cells were found at the myotendinous junction (MTJ)
(Fig. 2). Elongated SMA9/ScxGFP+ cells exist between collagen
fibers of the tendon body distal to the MTJ (Fig. 2D,I). A
combination of SMA9/ScxGFP+ and SMA9+ cells reside on the
tendon surface (Fig. 2H) near the MTJ and in the perimysium
surrounding the muscle that runs continuously with the tendon
sheath, as seen in the EDM tendon (Fig. 2F–G). SMA9+ muscle
fibers are observed at later time points following tamoxifen
injection (Fig. 2H–J).

tdTomato fluorescent signal overlays with the cell nucleus, the
binary dapi channel was used as a mask to quantify the mean
grayscale intensity of the tdTomato signal within the area of each
nucleus. The SMA9+ positive cells above a minimum intensity
threshold were then quantified and reported as percentage of the
total number of cells within the tendon midsubstance.
Injury study. The SMA9+ and ScxGFP+ cells were quantified from two photon image stacks at 1, 2, and 5 weeks postinjury. A minimum threshold was applied to each SMA9 and
ScxGFP stack to create binary images of positive intensity. The
positive area for each individual channel was quantified and the
two channels were overlaid to quantify the double positive
(SMA9+ ScxGFP) area. The SMA9, ScxGFP, and double positive
cell areas were quantified in 3 regions of interest (800 mm
long6400 mm wide) at distal, mid, and proximal regions of the
defect.

SMA9 Cells in the Tendon Midsubstance are an
Amplifying Resident Progenitor Population
Following the establishment that SMA9+ cells are found in 4
distinct populations in and around the tendon, we next questioned
whether the cells in the body of the tendon (population 4) are an
amplifying resident progenitor population that expands during
growth. Growing mice (3–4 week-old) were injected on consecutive days with tamoxifen and the patellar tendons were assessed at
2, 21, and 70 days post-injection. On day 2, SMA9+ cells are
found in all four populations described in the previous section
(Fig. 3A,D). The cells within the tendon midsubstance are
dispersed throughout the volume of the patellar tendon, constituting 3.161.5% of total cells (Fig. 3G), and they are all Scx+ (Fig.
S3). By day 21, the population at 2 days amplifies by over 4-fold to
13.564.4% of cells in the tendon midsubstance (p,0.05;
Fig. 3B,E,G). These cells appear to be dispersed throughout the
tendon volume and there is little evidence of clonal expansion
except within linear cell arrays, which show multiple labeled cells
in succession. This pattern is not consistent however as seen in
figure 1F where the SMA9+ cells alternate within the linear array.
It also appears that this expanded population came from the cells
labeled within the tendon body on day 2 and not cells within the
paratenon on day 2, as there is often space between the internal
population and tendon surface that did not contain SMA9+ cells
(Fig. S4). When the chase is assessed on 70 days following injection
(Fig. 3C,F), the number of cells in the tendon midsubstance
diminishes to day two levels (2.860.4%, Fig. 3G), suggesting that
the SMA9 model transiently labels an amplifying progenitor
source within the body of the tendon during growth.
While these cells have the ability to expand during growth
within the patellar tendon, other tendons show varying levels of
expansion. When comparing the number of SMA9+ cells at day
21 within the patellar, Achilles, and supraspinatus tendon, we find
that the expansion of SMA9 cells in the Achilles (2.561.3% of
total) is significantly reduced compared to the other tendons (p,
0.05; Fig. 3H). However, the number of SMA9 cells within the
patellar and supraspinatus tendons was comparable (13.564.4%
and 12.965.3, respectively).

Statistics
The number of SMA9+ cells in the patellar tendon during
growth was analyzed via one-way ANOVA with time postinjection as the fixed factor (p,0.05). The number of SMA9 cells
within multiple tendons was also compared at day 21 via one-way
ANOVA. Following injury, the area of SMA9, ScxGFP, and
double positive cells was analyzed via one-way MANOVA with
time post-surgery as the fixed factor (p,0.05).

Results
SMA9+ Cells Exist in 4 Distinct Populations in and around
Tendons
The resident tendon progenitors that contribute to postnatal
growth and normal cell turnover are not well characterized.
Lineage tracing of SMACre+ cells in 3–4 week-old SMA9 and
SMA9-ScxGFP mice was determined at 21 and 42 days post
tamoxifen activation (Figs. 1–2; anatomical locations for figures 1
and 2 can be found in figure S1). The labeled populations were
visualized in three dimensions using two photon microscopy and
defined by anatomical location, cell morphology, and/or GFP
reporter expression. Four distinct populations of cells in and
around tendons were identified: 1) circumferentially oriented, ringlike smooth muscle cells surrounded by adventitial collagen (as
seen by second harmonic generation signal in blue) in larger
vessels outside the tendon (Fig. 1A), 2) perivascular cells on the
surface of smaller vessels outside the tendon (Fig. 1A–B,G), 3) cells
in the paratenon (Fig. 1B, 2H), tendon sheath (Fig. 1D), or
retinaculum (Fig. 1G) surrounding the tendon body, and 4)
elongated SMA9-ScxGFP+ cells oriented between collagen fibers
within the tendon midsubstance (Fig. 1C,F,H). All four of these
populations are found in various limb tendons investigated in this
study including the patellar, Achilles, superficial digital flexor
(SDF), supraspinatus, and flexor/extensor tendons in the wrist at
21 and 42 days post-injection (Figs. 1–2).
SMA9+ cells in population 3 are either 1) situated within
circumferentially oriented collagen fibers in the paratenon
(Fig. 2H, S2), tendon sheath (Fig. 1D), or retinaculum (Fig. 1G)
or 2) residing on the outer surface of the tendon proper just
beneath the collagen fibers of the paratenon (Fig. 1B,E). The cells
on the tendon surface have a flattened morphology while cells
within the peritendinous structures are more elongated and
orientated along collagen fibers. Cells within population 3 are
primarily ScxGFP negative unlike cells in population 4 within the
tendon that are both SMA9+ and ScxGFP+ at all time points
investigated in this study (Figs. 1F,H and 2C,I), albeit the intensity
of the ScxGFP signal varies from cell to cell. These cells are highly
PLOS ONE | www.plosone.org

SMA9 Cells do not Contribute to Fibrocartilage in the
Tendon-to-Bone Insertion Site or Ligaments
While SMA9+ cells are found throughout the tendon midsubstance and myotendinous junction at all time points, there are no
SMA9+ cells in the fibrocartilage of the tendon-to-bone insertion
(Fig. 3A–C). This is true in every tendon evaluated in this study
and at every time point. There are also no SMA9+ cells in the
cruciate and collateral ligaments of the knee (see PCL in Fig. 3B–
C).
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Figure 1. SMA9 model labels 4 distinct cell populations in and around the tendon midsubstance. Following tamoxifen injection, SMA9+
cells (Red) are found in 1) smooth muscle cells in large blood vessels outside of the tendon (A), 2) perivascular cells in smaller vessels (A,B,G), 3)
paratenon/sheath/retinacular cells on the tendon surface (B,D,E,G), and 4) tendon fibroblasts within the midsubstance (C,F,H) of the patellar (PT),
flexor carpi ulnaris (FCU) tendon, Achilles (AT), and superficial digital flexor tendons (SDF) on 21 days (A–C,G) and 42 days (D–F,H) following injection.
Images and 3D reconstructions (G) were created using two photon microscopy in SMA9 (A–C,G) and SMA9-ScxGFP mice (D–F,H). SMA9+ cells within
the tendon body are ScxGFP+ (green) (F,H), unlike SMA9+ in the paratenon and tendon sheath (D–E). B&C are optical slices at the tendon surface and
50 mm deep in the PT, respectively. D–F are optical slices at the surface of the sheath, middle of the sheath, and 130 mm deep, respectively. G displays
SMA9+ cells in the retinaculum covering the SDF and AT. Blue – second harmonic generation (SHG) for collagen. Scale bars = 100 mm. The authors
encourage the readers to view figure S1 for the anatomical location of each panel in this figure.
doi:10.1371/journal.pone.0096113.g001
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Figure 2. SMA9+ cells are found in the tendon body, perimysium, and muscle fibers at the myotendinous junction. A–D) SMA9+ (red)
cells in the supraspinatus tendon (ST) span from the anterior surface near the enthesis (ENT) to the myotendinous junction (MTJ) at 42 days postinjection. E–G) SMA9+ and SMA9/ScxGFP+ cells are found at the muscle-tendon interface and in the perimysium (PM) of the extensor digiti minimi
(EDM) tendon at 21 days. Dotted lines in E–G refer to orthogonal slices in the x–y, x–z, and y–z planes. SMA9/ScxGFP+ tendon fibroblasts and SMA9+
paratenon cells and muscle fibers are found at the MTJ of the Achilles tendon (H–J) 42 days. H&I are optical slices at the tendon surface and 30 mm
deep in the AT, respectively (J is 3D reconstruction of H and I). All images were taken using two photon microscopy. Blue – second harmonic
generation (SHG) for collagen. Scale bars = 100 mm. Anatomical locations of images can be found in figure S1.
doi:10.1371/journal.pone.0096113.g002

extends from the tendon midsubstance, through the enthesis, and
into the underlying bone.
During these different stages of tendon and joint development,
GDF5-9+ cells are found within the fibrocartilage of the tendon
enthesis of the patellar and supraspinatus tendons (Fig. 4A,C,D,F).
A portion of cells isolated to the posterior half of the patellar
tendon midsubstance is also GDF5-9+ (Fig. 4A,D). In addition, all
ligamentous cells spanning from bone to bone are GDF5-9+ in the
cruciate and collateral ligaments of the knee (Fig. 4A,B,D,E).
There are also GDF5-9+ cells within the articular cartilage and
within the epiphyseal bone but they were not found within the
residual growth plate or the bone beneath the growth plate.

GDF5-9 Model Labels all Cells in Ligaments and Regions
of Tendon near Bone
Because SMA9+ cells are not found within the fibrocartilage of
the tendon enthesis or within the ligaments of the knee and
developmental studies show that distinct sets of progenitors form
the enthesis vs the midsubstance [2], we investigated whether
GDF5+ cells originating from the joint interzone would contribute
to these regions. We crossed GDF5Cre mice with Ai9 reporter
mice to demonstrate whether these regions came from Gdf5expressing cells. These mice were analyzed at P0 (during tendon
maturation) and P56 (during later stages of tendon growth). We
found that GDF5 labels a population of cells (GDF5-9+) that

PLOS ONE | www.plosone.org
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Figure 3. SMA9 model transiently labels an amplifying resident progenitor population in the tendon midsubstance during growth.
A pulse chase experiment where two tamoxifen injections were given on consecutive days to 3–4 week old mice revealed that the initial number
(3.161.5% of total) of resident SMA9+ cells (red, arrows) in the tendon midsubstance at 2 days (A,D,G) following injection expanded over 4-fold to
13.564.4% at 21 days (B,E,G) and then reduced to day 2 levels by 70 days (C,F,G). Trabecular bone in the tibia shows a similar trend, while muscle
fibers in the quadriceps were labeled at later time points (C). No SMA9+ cells were found in the fibrocartilage of the enthesis or ligaments in the knee
at any time point. In addition, the number of expanded cells on day 21 was significantly higher in the patellar (PT) and supraspinatus (ST) tendons
compared to the achilles (AT) tendon (H, p,0.05). Blue – dapi counterstained nuclei. PCL – posterior cruciate ligament. Scale bars = 250 mm.
*significantly different than other time points, ‘significantly different than other tendons. Error bars denote 6 SD.
doi:10.1371/journal.pone.0096113.g003

weeks following injury (Fig. S5B,F,J and 6K–T). SMA9+ cells
originating in the paratenon also infiltrate regions of the adjacent
tendon struts as they remodel following injury (Fig. 5J, 6Q, and
S5J,K). The thickened paratenon and remodeling regions of the
struts are rich in tenascin-C (Fig. S5E–G in green), which forms a
provisional matrix during healing.
The paratenon cells in the anterior bridge synthesize collagen
fibers that are aligned perpendicular to the tendon axis over the
adjacent struts as the cells expand from the anterior surfaces of the
medial and lateral retinaculum (Fig. 5K,L). The collagen within
the bridge consists of loose, small-diameter collagen fibers with
poor organization at 1 week (Fig. 5D,E). By 5 weeks, the collagen
matures in the bridge with thicker, densely packed fibers (Fig. 5K).

SMA9 Resident Progenitors are the Main Contributors to
Patellar Tendon Healing
Since SMA9 progenitor cells were found to contribute to cell
turnover during tendon growth, we next determined whether they
contribute to tendon healing in the adult. We utilized a full-length,
central-third patellar tendon defect injury used previously [20,25]
to examine the reparative potential of SMA9+ cells in the
paratenon and tendon midsubstance. One week following injury,
there is notable expansion of SMA9+ cells in the thickened
paratenon, which forms in response to injury (Fig. 5A–G and
S5A,E,I). The SMA9+ paratenon cells are initially found in the
medial and lateral surfaces of the retinaculum (S5A,E,I) as well as
on the surfaces of the tibia and patella (Fig. 5O,P). These SMA9+
cells expand to form an anterior bridge over the defect space by 2

PLOS ONE | www.plosone.org
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Figure 4. Unlike the SMA9 model, GDF5-9 cells are found within the fibrocartilage of the tendon enthesis and throughout the
length of ligaments. GDF5-9+ cells are expressed in cells within the cruciate ligaments (ACL, PCL) from bone to bone (A,B,D,E). GDF5-9+ cells are
concentrated near the enthesis of the supraspinatus tendon (ST) and do not extend along the length of the midsubstance (C,F). However, GDF5-9+
cells are found along the posterior half of the PT (A,D). GDF5-9 cells are also found within articular cartilage, menisci, collateral ligaments, synovium,
and epiphyseal bone in the knee. These expression patterns are similar between the ages of P0 (A–C) and P56 (D–F) except the epiphyseal bone is not
labeled at P0, which is before secondary ossification. Blue – dapi counterstained nuclei. LCL – lateral collateral ligament, MCL – medial collateral
ligament. Scale bars = 250 mm.
doi:10.1371/journal.pone.0096113.g004
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Figure 5. SMA9+ progenitors form a collagenous bridge over the anterior surface of the PT defect. Two photon imaging shows that
SMA9+ cells within the thickened paratenon synthesize collagen (SHG signal in blue and grey) as they form the paratenon bridge. These cells
originate from the medial and lateral tendon struts (G,N) and also from the anterior aspect of the tibia (O,P) and patella (data not shown). While these
cells originate from the paratenon and vasculature, they infiltrate the adjacent struts over time (J). The collagen in the bridge matures from 1 week
(A–G) to 5 weeks (H–U). G,N,U) 3D reconstructions in the axial view depicting the 3 levels in the anterior view (A–F, H–M, O–T). Scale bars = 100 mm.
doi:10.1371/journal.pone.0096113.g005

As the paratenon bridge continues to mature at 5 weeks, there is
reduced overlap in SMA9 and ScxGFP expression (18.169.3%).

However, the packing density is reduced compared to normal
tendon or the adjacent struts (Fig. 5M).
A minimal number of SMA9+ cells are found in the
contralateral, uninjured tendons (Fig. S5D,H,L). There are
SMA9+ cells in the paratenon and tendon midsubstance, along
with perivascular cells in small vessels outside of the tendon (Fig.
S5L). However, the cells in the paratenon and tendon midsubstance did not expand over the 5 week time frame in these adult
animals (Fig. S5H).

Discussion
Tendon is a composite structure with unique developmental
and mechanical characteristics. It connects two tissues with distinct
embryological origins: 1) bone from the sclerotome and 2) muscle
from the myotome. The coordinated patterning during embryonic
development involves separate progenitor pools to create the
enthesis, tendon midsubstance and myotendinous junction [2,3].
Once developed, tendons need to transmit tremendous contraction forces generated in the muscle down to the bone to enable
skeletal movement. This transition is mechanically demanding as
muscle and bone have orders of magnitude differences in
mechanical properties, thus the tendon must be stiff enough to
efficiently transfer load with minimal strain but also must integrate
with these mechanically distinct structures in a fashion that
reduces the stress concentrations at the interfaces. In addition, the
tendon needs to adapt to the somatic growth of the individual both
in terms of length and the increasing load it has to transmit
secondary to a larger body size and increased utilization. Defining
the cellular contributions to the tendon and its interaction with
bone and muscle will be fundamental to understanding the
molecular basis of this complex process.
Tendon has embryonic origins within Scx+ progenitors that
reside in the region of the sclerotome adjacent to the myotome,
known as the syndetome [1]. As the tendon condenses, Scx+/

SMA9+ Progenitors at 1 Week Post-injury Differentiate
into ScxGFP+ Cells at 2 Weeks Post-injury
While SMA9+ cells within the paratenon expand to form a
collagenous bridge over the defect space, we do not know if these
cells differentiate into ScxGFP+ tenogenic fibroblasts or are nonspecific scar fibroblasts. Therefore, we injured SMA9-ScxGFP
triple transgenic mice. At 1 week following injury, there is a
mixture of SMA9+ (white arrows, Fig. 6D–F, Video S1) and
ScxGFP+ cells within the paratenon bridge; however, only
12.568.0% of these cells are double positive (Fig. 6A–J,V). At 2
weeks when the collagen within the bridge matures, the SMA9+
cells within the collagen are also ScxGFP+ (yellow arrows, Fig. 6N–
P) while SMA9+ cells on the anterior surface above the mature
collagen are still ScxGFP negative (white arrows, Fig. 6K–M).
Taking these two populations into account, 65.5610.6% of the
total SMA9+ cells are SMA9-ScxGFP double positive at 2 weeks
(Fig. 6V), which is significantly greater than at one week (p,0.05).
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Figure 6. SMA9+ progenitors in the expanded paratenon differentiate into ScxGFP+ cells at 2 weeks post-injury. SMA9+ cells (white
arrows, D–F) at one week post-injury (A–J) are predominately negative for ScxGFP as seen in two photon image stacks in SMA9-ScxGFP mice.
However, these cells differentiate into ScxGFP+ cells (yellow arrows, N–P,V) at 2 weeks (K–T) within the collagenous regions of the paratenon bridge
while SMA9+ only cells still remain on the anterior surface (white arrows, K–M). By 5 weeks, there is reduced overlap in SMA9 and ScxGFP expression
(V). J,T) Axial views depicting the 3 levels in the anterior views (A–J, K–T) of the defects at 1 and 2 weeks, respectively. U) Total area of SMA9 and
ScxGFP positive signal at 1, 2, and 5 weeks. V) SMA9-ScxGFP double positive area normalized to either total SMA9 or ScxGFP area, respectively. Scale
bars = 100 mm. *significantly different than 1 and 5 weeks, ‘significantly different than 1 week (p,0.05). Error bars denote 6 SD. Full z-stacks can be
found in Video S1.
doi:10.1371/journal.pone.0096113.g006

expressed in nearly all cells within the tendon body. Therefore,
new markers are needed to characterize subtleties within the
tendon cell population that contribute to tendon growth and
maturation.
Our study has demonstrated that the SMA9 model marks an
amplifying progenitor population capable of generating tendon
cells, just as it does other mesenchymal tissues [9–12]. In the
weanling mice that we studied, these cells arise within the body of
the tendon and do not appear to migrate into the tendon from a
peritendinous site (Fig. S4). The amplifications of these cells, which
has not been seen previously using proliferation markers such as
BrdU, is transient as the number of SMA9+ cells reduces to
baseline levels after 10 weeks of expansion (Fig. 3G). Thus the

Sox9+ cells form a protrusion of fibrocartilage that anchors the
tendon to bone (enthesis) [2,3]. Concurrently, Scx+ progenitors at
the MTJ synthesize collagen fibrils that attach to actin filaments
within the sarcolemma to form the muscle attachment [26]. Once
the enthesis-MTJ unit is formed, the tendon begins to lengthen to
accommodate the somatic growth and to increase tendon fibril
diameter to transmit greater mechanical loads. These morphologic
changes suggest that both linear and appositional positioning of
the progenitor cells is a requirement for normal somatic growth.
Scx is required for proper tendon differentiation as it is initially
expressed in an early progenitor and remains active throughout
differentiation. Unfortunately, this means that Scx becomes less
useful to label a progenitor population in a growing tendon as it is
PLOS ONE | www.plosone.org
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Figure 7. SMA9+ cells from the paratenon/periosteum of the adjacent tendon and bone are the main contributors to PT healing.
Schematic depicts the origin and directional expansion of cells that contribute to PT defect healing. These cells originate within the paratenon in the
tendon and retinaculum of the medial/lateral aspects as well as paratenon/periosteum over the proximal and distal bones. As the cells form the
anterior bridge over the defect space, they begin to align along the tendon axis. MR – medial retinaculum, LR – lateral retinaculum.
doi:10.1371/journal.pone.0096113.g007

during embryogenesis, while Scx+ only progenitors form the
midsubstance [2]. These findings lend credence to the composite
nature of tendon and the heterogeneous origin of cells within these
regions.
One of the interesting outcomes of this study was that the
patellar tendon was the only tendon analyzed that had GDF5-9+
cells along the whole tendon length, spanning from patella to tibia
on the posterior side of the tendon. This contributes to the debate
on whether the patellar tendon is indeed a tendon or a ligament.
Anatomical, architectural, and cell lineage analysis suggests that it
may be a mixture of both. By the purest definition, the patellar
tendon is a ligament as it attaches bone (patella) to bone (tibia).
However, the patella is a specialized sesamoid bone that forms
from a pool of Scx+ progenitor cells during development, as
knocking out Sox9 in Scx-expressing cells will prevent the patella
from forming at all [2]. If the SMA9 model marks a consistent
progenitor pool from tendon to tendon but doesn’t label a pool
within ligaments, this suggests that the patellar tendon is more
tendon-like as well. However, GDF5, which is highly expressed in
ligaments, is also expressed on the posterior half of the patellar
tendon. Therefore, the patellar tendon has unique tendinous and
ligamentous properties.
In addition to SMA9+ progenitors cells’ contribution to tendon
growth, SMA9+ progenitors amplify following injury and are the
main contributors to healing of the central PT defect (Fig. 5–7).
These cells are found within an expanded paratenon that extends
from the adjacent retinaculum to span the defect space (Fig. 7). In
addition, cells from the periosteum on the anterior surface of the
tibia also expand in response to the tendon injury and work to fill
the space near the tibial insertion (Fig. 5O–U). Perivascular cells
within the expanded paratenon are also SMA9+ (Fig. 5I).
Unfortunately, we cannot discriminate between the relative

population of SMA9+ cells is gradually replaced by unmarked cells
as the tissue continues to grow in length and maturity. However,
further characterization of these cells is needed to understand their
phenotype and how to regulate their differentiation, especially
since immunostaining for aSMA shows minimal expression in
these cells (data not shown). Therefore, our future studies will
isolate the SMA9+ cells to develop an expression profile for these
early progenitors to characterize their phenotype and identify new
and possibly improved markers.
Interestingly, the expansion of SMA9 resident progenitors
differs from tendon to tendon. In fact, the number of SMA9+ cells
at 21 days following injection is significantly reduced in the
Achilles tendon compared to the patellar and supraspinatus
tendons (Fig. 3H), while numbers at 2 days were comparable
amongst these tendons (data not shown). The reduced expansion
seen in the Achilles midsubstance also correlates with reduced
mineral apposition rate of the mineralized fibrocartilage of the
enthesis (unpublished data) during this time period. The cause of
these differences is unknown and suggests that the cell and matrix
turnover of the Achilles is reduced at this age of growth, which is
puzzling as the Achilles continues to grow linearly with the tibia
during this period. It is possible that the mechanism of growth in
the Achilles may be different from other tendons.
While SMA9+ progenitors contribute to the tendon midsubstance, they do not contribute to cells within the fibrocartilage of
the tendon insertion, which are derived from GDF5-9+ cells.
GDF5-9+ cells contribute to the enthesis along with a segment of
the tendon midsubstance (Fig. 4). This lineage driver indicates that
the enthesis may develop from the interzone cells that generate the
structures within the forming joint space [15]. This observation is
consistent with previous work demonstrating that Scx+/Sox9+
progenitors, distinct from the primary cartilage, form the enthesis
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ulnaris (ECU) tendon in the wrist. The area for each panel in
figures 1 and 2 are denoted by black boxes. Panel E’ is high
magnification view of the red box in panel E.
(TIFF)

contribution of the paratenon and perivascular progenitors in this
SMA9 model, which is a limitation that requires additional
markers to isolate the perivascular from the paratenon populations.
As the repair process matures, the cells over the defect space
acquire an elongated morphology in parallel with the native
tendon and express the ScxGFP reporter (Fig. 6N). However few
of these cells become incorporated into the native tendon or fuse
with the ligated ends of the central tendon defect (Fig. 5Q,T).
Instead this new peritendinous tissue is distinctly separate from the
adjacent tendon and matures with time, leading to improved
mechanical properties [25]. Interestingly, the number of SMA9ScxGFP double-positive cells in the paratenon reduces from 2 to 5
weeks post-injury (Fig. 6V). This reduction could be caused by cell
turnover as there are fewer SMA9 cells at 5 weeks (Fig. 6U) or
these SMA9+ cells that were ScxGFP+ at 2 weeks are ScxGFP
negative at 5 weeks. We have previously shown that the
mechanical improvement of the healing tissue plateaus at 5 weeks
[25], which may suggest that maintaining Scx expression in these
cells for longer periods may lead to continued improvement and is
a focus of our future strategies.
We also see a similar mechanism of healing in response to long
bone fracture where SMA9+ progenitors within the periosteum
are the main contributors to the callus formation [9,27]. These
data combined suggest that adventitial structures surrounding both
tendon and bone, which are also highly vascularized, may hold a
reserve of SMA9+ progenitors that activate and amplify in
response to injury. A better understanding of the phenotype of
these progenitors and how to promote their differentiation during
healing will be critical for improving repair outcomes of these
injuries. Future studies will investigate these mechanisms using the
SMA9 model.
This study underlines the complexity and heterogeneity of cells
that initially form the midsubstance of tendons and subsequently
participate in a reparative response to injury. Although both map
to the similar SMA9+ progenitor sources, they appear to have
different locations and capabilities. Models of regeneration in the
intestine, hair follicle and hematopoietic system suggest that a
tissue resident stem cell undergoes asymmetrical division in which
the daughter cells have three potential fates: 1) return to a
quiescent and mitotically inactive state, 2) enter a differentiated
inactive state capable of rapid reactivation for formation of
multiple cell types, or 3) enter a pool of transient amplifying cells
with a constrained differentiation fate as seen with the SMA9
model during growth [28]. Stochastic factors that are inherent to
the tissue niche probably control which option the daughter stem/
progenitor cells choose. Genetic strategies to distinguish these
three states have been developed for epithelial tissues and this will
be the challenge for the skeletal biologist. Identifying cells within
the tendon and adjacent tissues and learning how to manipulate
their expansion and differentiation will be a requirement for
developing reparative strategies that might lead to a fully
functional and long-lived outcome.

Figure S2 Paratenon cells within circumferentially
oriented collagen fibers are SMA9+. Composite two photon
image of SMA9/ScxGFP Achilles tendon at 42 days postinjection. Arrows point to SMA9+ cell situated on collagen within
the paratenon, which wraps around the tendon surface. Red –
SMA9+ cells, Green – ScxGFP+ cells, Yellow/Orange – SMA9+/
ScxGFP+ cells, Blue – SHG for collagen.
(TIFF)
Figure S3 Two days following tamoxifen injection,
SMA9+ only cells are found within the paratenon (arrow
heads) on the tendon surface while SMA9+/ScxGFP+
cells are found within the tendon body (arrows). A–B) 3D
reconstruction in the anterior view of the patellar tendon where
the tendon axis runs in the y-direction. C–D) The 3D
reconstruction from A & B was rotated to an anterior-lateral
view. Red – SMA9+ cells, Green – ScxGFP+ cells, Yellow/
Orange – SMA9+/ScxGFP+ cells, Blue – SHG for collagen.
(TIFF)
Figure S4 There is often a gap between population 3 on
the tendon surface and population 4 within the tendon
body. A–B) Thin section in the transverse orientation of the PT of
a SMA9/ScxGFP mouse. C–D) 3D reconstruction in the anterior
view of the patellar tendon where the tendon axis runs in the ydirection. E–F) 3D reconstruction in the lateral view. G–H) 3D
reconstruction in the axial view. Red – SMA9+ cells, Green –
ScxGFP+ cells, Yellow/Orange – SMA9+/ScxGFP+ cells, Blue –
cell nuclei (A–B) and SHG for collagen (C,E,G).
(TIFF)
Figure S5 SMA9+ paratenon cells contribute to patellar

tendon defect healing. Full-length, central PT defects were
created in adult mice. Tamoxifen injections were delivered on the
day of surgery and the day following. SMA9+ progenitors within
the paratenon expand in response to injury, leading to a thickened
paratenon compared to normal tendon (D,H,L). By one week
(A,E,I), SMA9+ cells from the paratenon and perivasculature have
reached the defect space. A bridge over the anterior surface forms
by 2 weeks (B,F,J) and matures at 5 weeks (C,G,K). Tenascin-C
(green) is a major ECM component in this healing matrix where
the SMA9+ cells are located. A–D are toluidine stained sections.
Blue – dapi counterstained nuclei. Scale bars = 100 mm.
(TIFF)
Video S1 Multiphoton z-stacks of PT defects at 1, 2, and

5 weeks in SMA9-ScxGFP mice. 1st row – Red: SMA9,
Green: ScxGFP, Blue: SHG for collagen. 2nd row – Red: SMA9,
Green: ScxGFP. 3rd row – Gray: SHG for collagen. 4th row –
Transverse view of rows 1–3. Dotted line refers to depth within
tendon starting at anterior surface and moving deeper into tendon.
(AVI)

Supporting Information
Figure S1 Anatomical locations of images in figures 1
and 2. A) Posterior view of ankle depicting Achilles tendon (AT)
with overlapping superficial digital flexor (SDF) tendon. B)
Anterior view of patellar tendon (PT). C) Anterolateral view of
flexor carpi ulnaris (FCU) tendon in the wrist. D) Superior view of
supraspinatus tendon (ST) in shoulder following reflection of
deltoid muscle and clavicle/acromion. E) Posterolateral view of
extensor digiti minimi (EDM) tendon with adjacent extensor carpi
PLOS ONE | www.plosone.org
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